Home › Therapeutic areas › Renal › Hyperphosphatemia
Hyperphosphatemia (2 companies)
Companies with an active program in Hyperphosphatemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics | HematologyOphthalmology+2 Rare | 1 | Approved | $111M | 10 |
| UNCY | Unicycive Therapeutics | Renal | 1 | NDA Submitted | $98.9M | 2 |
No companies match.